We are live on ! Find out more
CAD

Craig A. Drill Portfolio holdings

AUM $24.4M
1-Year Est. Return 13.42%
This Fund
S&P 500
This Quarter Est. Return
+10.5%
1 Year Est. Return
+13.42%
3 Year Est. Return
+67.09%
5 Year Est. Return
10 Year Est. Return
AUM
$50.7M
AUM Growth
+$11.1M
Cap. Flow
+$9.01M
Cap. Flow %
17.77%
Top 10 Hldgs %
95.69%
Holding
19
New
4
Increased
3
Reduced
3
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 72.65%
2 Consumer Discretionary 16.32%
3 Consumer Staples 6.76%
4 Industrials 2.03%
5 Technology 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYNO
1
DELISTED
Cynosure, Inc. Class A
CYNO
$17.7M 34.93%
+364,300
New +$17.3M
BEAT
2
DELISTED
BioTelemetry, Inc.
BEAT
$7.33M 14.44%
449,473
-229,300
-34% -$3.37M
LBY
3
DELISTED
Libbey, Inc.
LBY
$6.83M 13.47%
430,116
-143,200
-25% -$2.46M
ZLTQ
4
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$6.29M 12.4%
230,200
-55,600
-19% -$1.56M
CENT icon
5
Central Garden & Pet Co
CENT
$2.74B
$3.43M 6.76%
187,750
ARLZ
6
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$1.93M 3.8%
584,600
+245,300
+72% +$926K
GIL icon
7
Gildan
GIL
$9.84B
$1.44M 2.84%
49,200
EVFM
8
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1.31M 2.57%
+14,811
New +$1.33M
ELOS
9
DELISTED
Syneron Medical Ltd
ELOS
$1.23M 2.42%
160,000
+117,000
+272% +$834K
RLGT icon
10
Radiant Logistics
RLGT
$408M
$1.03M 2.03%
343,200
ROKA
11
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$915K 1.8%
160,000
RVNC
12
DELISTED
Revance Therapeutics, Inc.
RVNC
$892K 1.76%
+65,600
New +$1.16M
GAIA icon
13
Gaia
GAIA
$39.4M
$222K 0.44%
28,650
GLMD icon
14
Galmed Pharmaceuticals
GLMD
$4.34M
$90K 0.18%
14
+7
+100% +$52.9K
AXGN icon
15
Axogen
AXGN
$2.77B
$69K 0.14%
+10,000
New +$56.6K
IRIX icon
16
IRIDEX
IRIX
$12.3M
-46,900
Closed -$479K
LUV icon
17
Southwest Airlines
LUV
$19.4B
-8,100
Closed -$363K
CUTR
18
DELISTED
Cutera, Inc.
CUTR
-74,896
Closed -$843K
SIEN
19
DELISTED
Sientra, Inc.
SIEN
-52,370
Closed -$3.58M

Similar funds

Craig A. Drill's Q2 2016 Portfolio in Review

As of Q2 2016, Craig A. Drill held 19 positions worth $50.7M, up 28% from $39.7M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Craig A. Drill deployed $9.01M of net new capital in Q2 2016, opening 4 new positions and adding to 3 existing holdings. Its largest new stake was Cynosure, Inc. Class A: 364,300 shares worth $17.7M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 56% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was BioTelemetry, Inc., an estimated $3.37M trimmed.

  • Craig A. Drill's largest Q2 2016 buy was Cynosure, Inc. Class A: 364,300 shares worth $17.7M.
  • Craig A. Drill added most to Aralez Pharmaceuticals Inc. in Q2 2016, an estimated $926K increase.
  • Craig A. Drill's biggest Q2 2016 reduction was BioTelemetry, Inc., cutting an estimated $3.37M.
  • Craig A. Drill fully exited Sientra, Inc. in Q2 2016, selling an estimated $3.58M.
  • Craig A. Drill's ten largest holdings make up 96% of its $50.7M portfolio in Q2 2016.
  • Craig A. Drill opened 4 new positions and closed 4 in Q2 2016.
  • Craig A. Drill's portfolio value rose 28% quarter-over-quarter to $50.7M.

Based on Craig A. Drill's 13F filing for Q2 2016, filed 4 Aug 2016.